CD9 and plasma cell myeloma: A later retrospective study investigated CD9 expression in bone marrow aspirates from 81 myeloma patients by flow cytometry and discovered that more patients with inactive disease expressed CD9 (60.7%) than those with active disease (33.9%) (De Bruyne et al., 2008).